Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Shah

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
Cancer|November 14, 2019
Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare databaseBita Fakhri, Mark A Fiala, Nina Shah, et al.
Clinical Drug Investigation|February 18, 2021
Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient PopulationsNina Shah, Matthew Sussman, Concetta Crivera, et al.
International Urology and Nephrology|September 1, 2005
The nephrologist as a primary care provider for the hemodialysis patientNina Shah, Naomi V Dahl, Toros Kapoian, et al.
Fertility and Sterility|August 20, 2008
The challenge of providing infertility services to a low-income immigrant Latino populationRobert D Nachtigall, Martha Castrillo, Nina Shah, et al.
Journal of Visualized Experiments : Jove|April 19, 2021
Comparative Analysis of Experimental Methods to Quantify Animal Activity in Caenorhabditis elegans Models of Mitochondrial DiseaseManuela Lavorato, Neal D Mathew, Nina Shah, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspectiveNina Shah, Katy Rezvani, Chitra Hosing, et al.
Drug and Alcohol Dependence|March 22, 2002
High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control studyCrystal M Fuller, David Vlahov, Danielle C Ompad, et al.
Leukemia & Lymphoma|January 14, 2020
A single-center retrospective cohort analysis of venetoclax in relapsed/refractory multiple myelomaSwetha Kambhampati, Derek Galligan, Chiung-Yu Huang, et al.
Oncology and Therapy|May 17, 2022
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United StatesSundar Jagannath, Nedra Joseph, Jinghua He, et al.
Oncology and Therapy|October 25, 2021
Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the USSundar Jagannath, Nedra Joseph, Jinghua He, et al.
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Cancer|November 14, 2019
Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare databaseBita Fakhri, Mark A Fiala, Nina Shah, et al.
Clinical Drug Investigation|February 18, 2021
Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient PopulationsNina Shah, Matthew Sussman, Concetta Crivera, et al.
International Urology and Nephrology|September 1, 2005
The nephrologist as a primary care provider for the hemodialysis patientNina Shah, Naomi V Dahl, Toros Kapoian, et al.
Fertility and Sterility|August 20, 2008
The challenge of providing infertility services to a low-income immigrant Latino populationRobert D Nachtigall, Martha Castrillo, Nina Shah, et al.
Journal of Visualized Experiments : Jove|April 19, 2021
Comparative Analysis of Experimental Methods to Quantify Animal Activity in Caenorhabditis elegans Models of Mitochondrial DiseaseManuela Lavorato, Neal D Mathew, Nina Shah, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspectiveNina Shah, Katy Rezvani, Chitra Hosing, et al.
Drug and Alcohol Dependence|March 22, 2002
High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control studyCrystal M Fuller, David Vlahov, Danielle C Ompad, et al.
Leukemia & Lymphoma|January 14, 2020
A single-center retrospective cohort analysis of venetoclax in relapsed/refractory multiple myelomaSwetha Kambhampati, Derek Galligan, Chiung-Yu Huang, et al.
Oncology and Therapy|May 17, 2022
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United StatesSundar Jagannath, Nedra Joseph, Jinghua He, et al.
Oncology and Therapy|October 25, 2021
Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the USSundar Jagannath, Nedra Joseph, Jinghua He, et al.
Pageof 18